Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Plos One
|
August 23, 2013
Structure and genetic content of the megaplasmids of neurotoxigenic clostridium butyricum type E strains from Italy
Angelo Iacobino, Concetta Scalfaro, Giovanna Franciosa
The Journal of Antibiotics
|
May 26, 2018
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions
Angelo Iacobino, Federico Giannoni, Lanfranco Fattorini, et al.
FEMS Microbiology Letters
|
April 4, 2017
Galleria mellonella as an in vivo model for assessing the protective activity of probiotics against gastrointestinal bacterial pathogens
Concetta Scalfaro, Angelo Iacobino, Chiara Nardis, et al.
Microorganisms
|
June 28, 2023
Eradication of Drug-Tolerant <i>Mycobacterium tuberculosis</i> 2022: Where We Stand
Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Annali Dell'Istituto Superiore Di Sanita
|
June 20, 2023
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020
Federico Giannoni, Alessio Lanni, Angelo Iacobino, et al.
Frontiers in Microbiology
|
August 18, 2025
Activity of combinations of bactericidal and bacteriostatic compounds in <i>Mycobacterium abscessus</i>-infected mice: an overview
Alessio Lanni, Elisabetta Iona, Lanfranco Fattorini, et al.
Frontiers in Microbiology
|
March 5, 2016
Effects of Megaplasmid Loss on Growth of Neurotoxigenic Clostridium butyricum Strains and Botulinum Neurotoxin Type E Expression
Concetta Scalfaro, Angelo Iacobino, Laura Grande, et al.
Microorganisms
|
January 30, 2021
Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent Manner
Angelo Iacobino, Giovanni Piccaro, Manuela Pardini, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2016
Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH
Angelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy
|
April 24, 2019
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH
Angelo Iacobino, Federico Giannoni, Manuela Pardini, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Plos One
|
August 23, 2013
Structure and genetic content of the megaplasmids of neurotoxigenic clostridium butyricum type E strains from Italy
Angelo Iacobino, Concetta Scalfaro, Giovanna Franciosa
The Journal of Antibiotics
|
May 26, 2018
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions
Angelo Iacobino, Federico Giannoni, Lanfranco Fattorini, et al.
FEMS Microbiology Letters
|
April 4, 2017
Galleria mellonella as an in vivo model for assessing the protective activity of probiotics against gastrointestinal bacterial pathogens
Concetta Scalfaro, Angelo Iacobino, Chiara Nardis, et al.
Microorganisms
|
June 28, 2023
Eradication of Drug-Tolerant <i>Mycobacterium tuberculosis</i> 2022: Where We Stand
Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Annali Dell'Istituto Superiore Di Sanita
|
June 20, 2023
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020
Federico Giannoni, Alessio Lanni, Angelo Iacobino, et al.
Frontiers in Microbiology
|
August 18, 2025
Activity of combinations of bactericidal and bacteriostatic compounds in <i>Mycobacterium abscessus</i>-infected mice: an overview
Alessio Lanni, Elisabetta Iona, Lanfranco Fattorini, et al.
Frontiers in Microbiology
|
March 5, 2016
Effects of Megaplasmid Loss on Growth of Neurotoxigenic Clostridium butyricum Strains and Botulinum Neurotoxin Type E Expression
Concetta Scalfaro, Angelo Iacobino, Laura Grande, et al.
Microorganisms
|
January 30, 2021
Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent Manner
Angelo Iacobino, Giovanni Piccaro, Manuela Pardini, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2016
Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH
Angelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy
|
April 24, 2019
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH
Angelo Iacobino, Federico Giannoni, Manuela Pardini, et al.
Page
of 3